Susceptibility of colorectal cancer cells to sindbis virus infection

Journal of Experimental Therapeutics and Oncology

Volumn 8, Issue 2, 2009, Pages 167-175

  Li, Chao ^a   Gu, Youling ^a   Andrade, Dario ^a   Liu, Yuechueng ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Colorectal cancer; Laminin receptor; Oncolytic virus; Sindbis virus

Indexed keywords

LAMININ RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER GROWTH; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFECTION RATE; INFECTION RESISTANCE; INFECTION SENSITIVITY; INVASIVE CARCINOMA; LEUKEMIA; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; SINDBIS VIRUS; TARGET CELL; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INFECTION; VIRUS INFECTIVITY;

ALPHAVIRUS INFECTIONS; ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; HUMANS; MALE; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; RECEPTORS, LAMININ; SINDBIS VIRUS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 74049119455     PISSN: 13594117     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Wollmann G, Tattersall P, van den Pol AN. Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential. J Virol 79: 6005-6022, 2005.
2. Bell JC, Lichty B, Stojdl D. Getting oncolytic virus therapies off the ground. Cancer Cell 4: 7-11, 2003.
3. Fisher K. Striking out at disseminated metastases: the systemic delivery of oncolytic viruses. Curr Opin Mol Ther 8: 301-313, 2006.
4. Varghese S, Rabkin SD, Nielsen GP, MacGarvey U, Liu R, Martuza RL. Systemic therapy of spontaneous prostate cancer in transgenic mice with oncolytic herpes simplex viruses. Cancer Res 67: 9371-9379, 2007.
5. Bischoff JR, Kirn DH, Williams A, Heise C, Horn S, et al. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274: 373-376, 1996.
6. Vidal L, Pandha HS, Yap TA, White CL, Twigger K, et al. A phase I study of intravenous oncolytic reovirus type 3 Dearing in patients with advanced cancer. Clin Cancer Res 14: 7127-7137, 2008.
7. Hay JG. Sindbis virus - an effective targeted cancer therapeutic. Trends Biotechnol 22: 501-503, 2004.
8. Taylor RM, Hurlbut HS, Work TH, Kingston JR, Frothingham TE. Sindbis virus: a newly recognized arthropodtransmitted virus. Am J Trop Med Hyg 4: 844-862, 1955.
9. Strauss EG, Rice CM, Strauss JH. Complete nucleotide sequence of the genomic RNA of Sindbis virus. Virology 133: 92-110, 1984.
10. DeTulleo L, Kirchhausen T. The clathrin endocytic pathway in viral infection. Embo J 17: 4585-4593, 1998.
11. Strauss EG, De Groot RJ, Levinson R, Strauss JH. Identification of the active site residues in the nsP2 proteinase of Sindbis virus. Virology 191: 932-940, 1992.
12. Shirako Y, Strauss JH. Regulation of Sindbis virus RNA replication: uncleaved P123 and nsP4 function in minus-strand RNA synthesis, whereas cleaved products from P123 are required for efficient plus-strand RNA synthesis. J Virol 68: 1874-1885, 1994.
13. Lemm JA, Rice CM. Roles of nonstructural polyproteins and cleavage products in regulating Sindbis virus RNA replication and transcription. J Virol 67: 1916-1926, 1993.
14. Derrick SC, Yang AL, Morris SL. Vaccination with a Sindbis virus-based DNA vaccine expressing antigen 85B induces protective immunity against Mycobacterium tuberculosis. Infect Immun 73: 7727-7735, 2005.
15. Levine B, Huang Q, Isaacs JT, Reed JC, Griffin DE, Hardwick JM. Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene. Nature 361: 739-742, 1993.
16. Wang KS, Kuhn RJ, Strauss EG, Ou S, Strauss JH. High-affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J Virol 66: 4992-5001, 1992.
17. Tseng JC, Levin B, Hirano T, Yee H, Pampeno C, Meruelo D. In vivo antitumor activity of Sindbis viral vectors. J Natl Cancer Inst 94: 1790-1802, 2002.
18. Tseng JC, Levin B, Hurtado A, Yee H, Perez de Castro I, et al. Systemic tumor targeting and killing by Sindbis viral vectors. Nat Biotechnol 22: 70-77, 2004.
19. Unno Y, Shino Y, Kondo F, Igarashi N, Wang G, et al. Oncolytic viral therapy for cervical and ovarian cancer cells by Sindbis virus AR339 strain. Clin Cancer Res 11: 4553-4560, 2005.
20. Hahn CS, Hahn YS, Braciale TJ, Rice CM. Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation. Proc Natl Acad Sci U S A 89: 2679-2683, 1992.
21. Leibovitz A, Stinson JC, McCombs WB, 3rd, McCoy CE, Mazur KC, Mabry ND. Classification of human colorectal adenocarcinoma cell lines. Cancer Res 36: 4562-4569, 1976.
22. Hewitt RE, McMarlin A, Kleiner D, Wersto R, Martin P, et al. Validation of a model of colon cancer progression. J Pathol 192: 446-454, 2000.
23. Flatmark K, Maelandsmo GM, Martinsen M, Rasmussen H, Fodstad O. Twelve colorectal cancer cell lines exhibit highly variable growth and metastatic capacities in an orthotopic model in nude mice. Eur J Cancer 40: 1593-1598, 2004.
24. Huang HV. Sindbis virus vectors for expression in animal cells. Curr Opin Biotechnol 7: 531-535, 1996.
25. Sanjuan X, Fernandez PL, Miquel R, Munoz J, Castronovo V, et al. Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma. J Pathol 179: 376-380, 1996.
26. Byrnes AP, Griffin DE. Binding of Sindbis virus to cell surface heparan sulfate. J Virol 72: 7349-7356, 1998.